An allied reprogramming, selection, expansion and differentiation platform for creating hiPSC on microcarriers.

Area of Science:

• Stem Cell Biology
• Biotechnology

Background:

• Monolayer cultures for induced pluripotent stem cells (iPSCs) suffer from low efficiency, extensive manipulation, and operator variability.
• Developing robust and scalable methods for iPSC generation is crucial for regenerative medicine and drug discovery.

Purpose of the Study:

• To develop and validate a microcarrier-based platform for the reprogramming, expansion, and differentiation of human somatic cells into iPSCs.
• To overcome the limitations of conventional monolayer cell culture techniques.

Main Methods:

• Human somatic cells from five sources were reprogrammed, selected, expanded, and differentiated using microcarrier suspension cultures.
• The process involved integrated expansion without trypsinization and differentiation without embryoid body formation.

Main Results:

• Microcarrier cultures demonstrated up to a 2-fold increase in transduction efficiency and accelerated reprogramming by 7 days compared to monolayer cultures.
• This resulted in 30-50 fold more clones, with earlier induction of key genes (β-catenin, E-cadherin, EpCAM) and faster pluripotency gene stabilization.
• Efficient differentiation into three germ layers, cardiomyocytes, and hematopoietic stem cells was achieved.

Conclusions:

• The microcarrier platform offers a highly efficient, labor-saving, and automation-compatible alternative to monolayer iPSC culture.
• It eliminates the need for cell dissociation and embryoid body formation, simplifying the process and improving reproducibility.
• This method addresses key challenges in manual iPSC selection and processing.